Northern Trust’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Hold
149,194
﹤0.01% 3871
2025
Q4
$295K Buy
149,194
+18,024
+14% +$57.7K ﹤0.01% 3842
2025
Q3
$382K Buy
131,170
+29,495
+29% +$67.8K ﹤0.01% 3744
2025
Q2
$184K Sell
101,675
-267,415
-72% -$476K ﹤0.01% 3963
2025
Q1
$554K Sell
369,090
-37,472
-9% -$94.6K ﹤0.01% 3536
2024
Q4
$959K Buy
406,562
+10,782
+3% +$189K ﹤0.01% 3413
2024
Q3
$11.6M Buy
395,780
+17,437
+5% +$402K ﹤0.01% 1977
2024
Q2
$4.67M Sell
378,343
-475
-0.1% -$10K ﹤0.01% 2441
2024
Q1
$7.69M Sell
378,818
-8,848
-2% -$204K ﹤0.01% 2213
2023
Q4
$8.73M Buy
387,666
+14,032
+4% +$296K ﹤0.01% 2158
2023
Q3
$6.22M Buy
373,634
+2,996
+0.8% +$59.4K ﹤0.01% 2308
2023
Q2
$9.09M Buy
370,638
+10,215
+3% +$246K ﹤0.01% 2130
2023
Q1
$8.69M Buy
360,423
+7,880
+2% +$218K ﹤0.01% 2113
2022
Q4
$10.4M Sell
352,543
-394
-0.1% -$14.2K ﹤0.01% 1979
2022
Q3
$14.8M Sell
352,937
-5,409
-2% -$146K ﹤0.01% 1705
2022
Q2
$10.1M Sell
358,346
-6,146
-2% -$155K ﹤0.01% 2029
2022
Q1
$13.5M Sell
364,492
-15,335
-4% -$650K ﹤0.01% 1951
2021
Q4
$16.6M Sell
379,827
-828
-0.2% -$43.4K ﹤0.01% 1905
2021
Q3
$23.6M Buy
380,655
+146,291
+62% +$12.2M ﹤0.01% 1675
2021
Q2
$20M Sell
234,364
-105,957
-31% -$5.68M ﹤0.01% 1877
2021
Q1
$15.3M Sell
340,321
-8,697
-2% -$342K ﹤0.01% 2012
2020
Q4
$2.38M Buy
349,018
+90,918
+35% +$812K ﹤0.01% 3112
2020
Q3
$2.97M Sell
258,100
-6,671
-3% -$30.1K ﹤0.01% 2851
2020
Q2
$815K Buy
264,771
+228,613
+632% +$1.04M ﹤0.01% 3424
2020
Q1
$148K Buy
36,158
+13,084
+57% +$86.6K ﹤0.01% 3747
2019
Q4
$120K Buy
23,074
+5,390
+30% +$9.3K ﹤0.01% 3901
2019
Q3
$21K Sell
17,684
-1,000
-5% -$1.28K ﹤0.01% 4148
2019
Q2
$23K Hold
18,684
﹤0.01% 4158
2019
Q1
$24K Hold
18,684
﹤0.01% 4116
2018
Q4
$16K Sell
18,684
-23,362
-56% -$26.9K ﹤0.01% 4164
2018
Q3
$43K Hold
42,046
﹤0.01% 4153
2018
Q2
$87K Buy
42,046
+3,902
+10% +$33.5K ﹤0.01% 4038
2018
Q1
$270K Buy
38,144
+23,062
+153% +$156K ﹤0.01% 3742
2017
Q4
$60K Buy
15,082
+446
+3% +$1.8K ﹤0.01% 4048
2017
Q3
$59K Buy
14,636
+800
+6% +$2.86K ﹤0.01% 4039
2017
Q2
$57K Buy
13,836
+531
+4% +$2.51K ﹤0.01% 4062
2017
Q1
$83K Sell
13,305
-16
-0.1% -$73 ﹤0.01% 3995
2016
Q4
$53K Buy
13,321
+440
+3% +$2.04K ﹤0.01% 4004
2016
Q3
$90K Hold
12,881
﹤0.01% 3918
2016
Q2
$197K Buy
12,881
+2,222
+21% +$35.2K ﹤0.01% 3733
2016
Q1
$166K Buy
10,659
+690
+7% +$8.93K ﹤0.01% 3792
2015
Q4
$122K Hold
9,969
﹤0.01% 3895
2015
Q3
$127K Sell
9,969
-43,238
-81% -$546K ﹤0.01% 3872
2015
Q2
$644K Sell
53,207
-7,787
-13% -$107K ﹤0.01% 3490
2015
Q1
$807K Sell
60,994
-165
-0.3% -$2.23K ﹤0.01% 3465
2014
Q4
$870K Buy
61,159
+313
+0.5% +$5.42K ﹤0.01% 3427
2014
Q3
$1.67M Buy
60,846
+42,781
+237% +$1.3M ﹤0.01% 3213
2014
Q2
$727K Buy
18,065
+5,215
+41% +$193K ﹤0.01% 3507
2014
Q1
$495K Sell
12,850
-229
-2% -$8.08K ﹤0.01% 3546
2013
Q4
$445K Buy
13,079
+268
+2% +$7.12K ﹤0.01% 3533
2013
Q3
$244K Sell
12,811
-45,820
-78% -$801K ﹤0.01% 3616
2013
Q2
$907K Buy
+58,631
New +$1.24M ﹤0.01% 3296

Other funds holding FLNA

Northern Trust's FLNA Position: Q1 2026 in Review

Northern Trust held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 149,194 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #3871.

Northern Trust first reported a position in FLNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.6M in Q3 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Northern Trust held 149,194 shares of Filana Therapeutics worth $252K as of Q1 2026.
  • Northern Trust left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3871 holding.
  • Northern Trust first reported a position in Filana Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's Filana Therapeutics position peaked at $23.6M in Q3 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.